CoChat

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

Kalaria, D. R., Sharma, G., Beniwal, V., Ravi Kumar, M. N. V. · 2009 · Pharmaceutical Research

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Purpose Doxorubicin, a potent anticancer drug associated with cardiotoxicity and low oral bioavailability, was loaded into nanoparticles with a view to improve its performance.Methods Doxorubicin loaded PLGA nanoparticles were prepared by a double emulsion method. The pH dependent stability of nanoparticles in simulated fluids was evaluated. DSC and XRD studies were carried out in order to ascertain the nature of doxorubicin in formulations in conjunction with accelerated stability studies. The in vitro release was investigated in phosphate buffer. The pharmacokinetic and toxicity studies were conducted in rats.Results Nanoparticles had an average size of 185 nm, with 49% entrapment at 10% w/w of polymer. The particles displayed good pH dependent stability in the pH range 1.1-7.4. DSC and XRD studies revealed the amorphous nature of doxorubicin in nanoparticles and the accelerated stability studies revealed the integrity of formulations. Initial biphasic release (20%) followed by a sustained release (80%) for 24 days was observed under in vitro conditions. The doxorubicin loaded nanoparticles demonstrated superior performance in vivo as evident by enhanced bioavailability and lower toxicity.Conclusions Together, the data indicates the potential of doxorubicin loaded nanoparticles for oral chemotherapy. Further, these formulations could be explored for new indications like leishmaniasis.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11095-008-9763-4

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. S. K. Carter. Adriamycin—thoughts for the future. Chemother. Rep. Cancer. 63:877–883 (1975).

Cited by

See all 247

Metadata

Authors
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V.
Affiliations
  • National Institute of Pharmaceutical Education and Research (IN)
  • University of Strathclyde (GB)
Venue
Pharmaceutical Research
Published
2008-11-08
Volume
26
Issue
3
Pages
492-501
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W2050181086
Cited by
246
References
29
Citations by year
2026: 4 · 2025: 5 · 2024: 15 · 2023: 3 · 2022: 7 · 2021: 10 · 2020: 17 · 2019: 18 · 2018: 15 · 2017: 16 · 2016: 15 · 2015: 20 · 2014: 20 · 2013: 28 · 2012: 19
FWCI
4.86
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Pharmaceutical Research (publishedVersion)
  • PubMed (publishedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
doxorubicin, PLGA nanoparticles, oral drug delivery, oral bioavailability, pharmacokinetics, toxicity, pH-dependent stability, sustained drug release, amorphous drug, cardiotoxicity, leishmaniasis
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Administration, Oral, Animals, Antibiotics, Antineoplastic, Biocompatible Materials, Biological Availability, Calorimetry, Differential Scanning, Doxorubicin, Drug Carriers, Drug Stability, Female, Hydrogen-Ion Concentration, Particle Size, Polyglycolic Acid, Solubility, Surface Properties, X-Ray Diffraction, Drug Design, Rats, Sprague-Dawley, Lactic Acid, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats. https://app.cochat.ai/papers/10.1007/s11095-008-9763-4
The paper
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009). Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats. Pharmaceutical Research. https://doi.org/10.1007/s11095-008-9763-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.